Objective: Anxiety and substance use disorders are highly comorbid and mutually maintain each other. Treatments for anxiety disorders that are well integrated into substance use disorder treatment have the potential to improve both anxiety and substance use outcomes. Method: Ninety-seven individuals seeking treatment at a community-based, evidence-based intensive outpatient program for substance use disorders who also had anxiety disorders were randomized to either (a) usual care (UC) at the intensive outpatient program; or (b) UC ϩ coordinated anxiety learning and management for addiction recovery centers (CALM ARC), a 7-session, group-based, computer-assisted but therapist-directed treatment for anxiety disorders adapted for individuals with anxiety disorder and substance use disorder comorbidity. Results: CALM ARC ϩ UC outperformed UC on measures of anxiety and substance use at posttreatment and at a 6-month follow-up. Conclusions: Adding CALM ARC to UC for patients with comorbid anxiety disorders and substance use disorders is superior to UC alone. Implications for future research and clinical practice are discussed.
The comorbidity of anxiety disorders and substance use disorders (SUD) is well documented (Compton, Thomas, Stinson, & Grant, 2007; Grant et al., 2004) . Anxiety disorder comorbidity among those with SUDs is associated with greater clinical severity (Burns, Teesson, & O'Neill, 2005; Glasner-Edwards et al., 2010) and poorer treatment outcomes (Smith & Book, 2010; Kushner et al., 2005) compared with those with SUDs only, making it a significant public health concern. Although effective treatments for anxiety disorders exist, with cognitive-behavioral therapy (CBT) considered the treatment of choice (Arch & Craske, 2008) , most individuals with anxiety disorders do not receive these treatments (Santucci, McHugh, & Barlow, 2012) . Thus, greater accessibility to CBT for anxiety disorders is needed. SUD specialty clinics represent settings with an elevated prevalence of anxiety disorders that typically go untreated (e.g., McGovern, Xie, Segal, Siembab, & Drake, 2006) and thus may be an important clinical setting to target.
Introducing CBT for anxiety disorders into SUD community practice settings has the potential to improve not only anxiety but also SUD outcomes. Despite the advances in SUD treatment, relapse rates, and treatment dropout remain high (Dutra et al., 2008; Krawczyk et al., 2017) . One possible way to improve SUD outcomes is to treat underlying negative affective states such as anxiety that may maintain and exacerbate problems with substance use (Stewart & Conrod, 2008) . Models of care that integrate anxiety treatment into SUD treatment may be optimal to mitigate the mutual maintenance of anxiety and SUD symptoms. Indeed, studies examining the effects of anxiety disorder treatment on SUD outcomes are limited, with mixed findings (see Wolitzky-Taylor, Operskalski, Ries, Craske, & RoyByrne, 2011) , but the few studies that have integrated CBT for posttraumatic stress disorder (Najavits, Gallop, & Weiss, 2006) and panic disorder (Kushner et al., 2006) into SUD treatment have had more favorable outcomes than non-integrated treatments. CBT for anxiety disorders that is well integrated into SUD treatment may be more clinically relevant, consistent, and manageable for patients and their providers.
The Coordinated Anxiety Learning and Management (CALM) Study developed a computerized, therapist-directed CBT protocol for anxiety disorders that was delivered in primary care by nurses and social workers without previous CBT training (Craske et al., 2009) . The CBT program focused on teaching overarching cognitive and behavioral skills and principles relevant across the anxiety disorders. CALM demonstrated moderate effect sizes compared with usual care in a large effectiveness trial (Roy-Byrne et al., 2010) . Given its success, we aimed to develop and evaluate an adaptation of CALM for patients in SUD specialty clinics with comorbid anxiety disorders, which we called CALM for Addiction Recovery Centers (CALM ARC). The development of CALM ARC focused on creating a CBT program for anxiety disorders that would fit within the structure and culture of SUD specialty clinics to increase the likelihood of adoption and sustainability in clinical practice. As a result, we developed a brief, group-based CBT program for anxiety disorders that was delivered by SUD counselors using a CALM-like model: a computerized, therapistdirected, highly structured, and interactive program. Utilizing a hybrid efficacy/effectiveness randomized clinical trial design to balance internal and external validity, our aim was to evaluate the preliminary effectiveness of CALM ARC in reducing anxiety and substance use symptoms among patients with comorbid anxiety disorders and SUD enrolled in a community-based, evidencebased SUD intensive outpatient program (IOP) compared with the evidence-based SUD IOP treatment alone. We hypothesized that those randomized to usual care (UC) ϩ CALM ARC would show superior outcomes on measures of anxiety and substance use compared with those randomized to receive only UC.
Method Experimental Design and Randomization
See Table 1 for the assessment schedule and randomization procedures and Figure 1 for the design and flow of participants.
Participants
Inclusion and exclusion criteria are presented in Table 1 . Demographic characteristics of the final sample (N ϭ 75) who completed at least a pretreatment assessment are presented in Table 3 .
Measures
Baseline eligibility screening. Patients who enrolled at the community SUD clinic were invited to complete an anxiety screening measure (i.e., Overall Anxiety Severity and Impairment Scale; Campbell-Sills et al., 2009) at their intake appointment or during their treatment. Those with scores Ն8 were invited to a baseline eligibility assessment, details of which are reported in Table 1 .
Outcome measures. Outcome measures are described in Table 1 . Measures of therapist fidelity and patient treatment adherence. Therapist fidelity ratings (comprised of adherence and competence) were conducted on 22.3% of CALM ARC sessions by an independent licensed clinical psychologist with expertise in CBT for anxiety disorders. Adherence was determined by calculating the percentage of assigned components delivered in a given session. Competence was rated on a 0 (not at all competent) to 6 (highly competent) scale for each session. Participant adherence to CALM ARC was evaluated via weekly clinician ratings of participant homework compliance on a scale from 0 (no homework completed) to 7 (all homework completed) and by examining the number of CALM ARC sessions completed.
Procedures
Assessment procedures. Interview-based assessments were conducted by research staff at the clinic. After randomization, participants in both conditions were given personal log-in access to the CALM ARC Web program, where questionnaires were completed.
1
Treatment conditions. CALM ARC is a brief (orientation ϩ six sessions), group-based, computerized but therapist-directed CBT program for anxiety disorders to be delivered by SUD treatment counselors to patients with comorbid anxiety disorders and SUD in SUD specialty clinics. Similar to the original CALM study (Roy-Byrne et al., 2010) but adapted for a group setting, CALM ARC was outlined in a Web-based program. This allowed clini-1 UC participants had access only to the weekly assessments and not to the CALM ARC treatment material. This document is copyrighted by the American Psychological Association or one of its allied publishers.
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cians with limited training in delivering CBT for anxiety disorders to deliver the treatment with a high level of adherence. Clinicians used the interactive Web-based program as a guide to deliver the treatment material. Therapist-directed sessions had corresponding home practice sections that allowed participants to enter responses to homework assignments, watch videos, and access material. Components of CALM ARC and integrated features are described in Table 2 . UC at the Matrix Institute IOP is CBT based with elements of 12-step facilitation and traditional relapse prevention for SUD. For a description of and evidence for the Matrix Model, see Rawson et al. (1995) . Controlling for therapy time. Participants randomized to CALM ARC attended CALM ARC group sessions in lieu of the family education group during the 7 weeks of CALM ARC and then resumed family education.
Therapist training and competency testing. Therapist training included didactics, role plays, and watching videos developed for CALM ARC demonstrating therapy skills with mock patients. After training, therapists (n ϭ 2) completed a knowledge quiz and were tested on their competence to deliver CBT skills in standardized role plays. Therapists were permitted to deliver CALM ARC when they achieved at least an 80% on the knowledge quiz and when their average role play scores were rated as at least adequate (i.e., Ն4 of 7) on the Yale Adherence and Competence Scale (Corvino, Carroll, Nuro, Nich, & Sifry, 2000) for at least four of the six role plays conducted for each anxiety disorder. The two therapists' average knowledge quiz score was 96.06%. Their average Yale Adherence and Competence Scale ratings across role plays ranged from 3.92 (SD ϭ 0.12) to 4.91 (0.12), indicating therapists learned to adequately deliver CBT for anxiety disorders prior to delivering CALM ARC. Therapists received weekly supervision during the trial. The training protocol and competency testing materials are available by request. The participant tracking and locating form is commonly used in SUD clinical trials to locate patients with SUD during the follow-up period (Hall et al., 2003) and was used to increase retention. Pretreatment assessment Substance use (alcohol and drug use, specifying drug type) in past 30 days (timeline followback; Sobell & Sobell, 1995) Because of the heterogeneity of substances of dependence used in this real-world clinical sample and the fact that more than 60.3% of the sample met the SUD criteria for more than one substance of dependence, the TLFB was used because it allowed for assessment across a variety of substances of dependence. Interviewers were blind to condition. Interrater reliability was assessed on 22.9% of the TLFB interviews, with 100% agreement. Anxiety (BSI-12; Derogatis, 1993) Cronbach's ␣ ϭ .86 for the BSI in this sample Week 1 (of CALM ARC or matched assessment in UC) a. Treatment credibility and expectancy a. Modified version of CEQ (Devilly & Borkovec, 2000 This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Statistical Analysis
One-way ANOVAs, t tests, and 2 tests were used to examine between-group differences on demographic and baseline clinical characteristics, and measures were collected at one time point. Our analyses of anxiety and substance use outcomes utilized a series of multilevel models (using SPSS Mixed; SPSS Inc., Chicago, IL) with time as a level 1 predictor and condition (CALM ARC ϩ UC, UC) as a level 2 predictor of intercept and linear slope, which were both allowed to vary randomly across participants. These analyses involved two outcome observations at a time (e.g., before and after; after and follow-up) to examine within-and between-group effects from before to after treatment and separately to examine the maintenance of treatment effects by comparing posttreatment and follow-up observations. We utilized all data that were collected (regardless of whether participants completed their treatment protocol) and included any participant who completed at least one assessment (i.e., before treatment). No significant correlations were observed between completion of either posttreatment or follow-up assessments and key pretreatment demographic or clinical severity measures, suggesting that the assumption of a missing at random mechanism is likely to be reasonable for these data.
To avoid potential bias in the assessment of treatment effects because of missing data, we imputed values for the outcome variables across the entire span of the study using SPSS Multiple Imputation. 2 We report analyses of the imputed data and footnote those instances in which the findings from multilevel models using the original data set-which address missingness though full information maximum likelihood estimation limited to only the small set of variables included in a given analysis-differ. Assumptions of all strategies were met.
Results

Sample Characteristics, Treatment Credibility, and Treatment Expectancy
See Table 3 for diagnostic information. No between-group differences were observed on the number of days between matrix IOP intake and pretreatment assessment in the study, baseline symptom severity measures (see Table 4 ), demographics, clinical characteristics, perceived treatment credibility, or treatment expectancies (ps Ն .06).
2 Missing BSI scale scores and timeline followback drinking days and timeline followback drug use days values were imputed in 20 data sets using fully conditional specification with a between-imputation interval of 600 iterations. a Of the 11 ineligible, six were because of no anxiety disorder diagnosis, three were because of uncontrolled psychotic features, one was because of active suicidality, and one was because of psychotic features and uncontrolled bipolar disorder. Randomization was conducted on a rolling basis during 6-week standardized periods of randomization into one cohort or another to more quickly enroll sufficient numbers of participants into a group (National Institute on Drug Abuse, 2003).
b Conducted 1 week prior to initiation of CALM ARC sessions or the matched weekly assessments in UC; attrition in both conditions between baseline eligibility/randomization and pretreatment was due to treatment dropout from Matrix for a variety of reasons.
c Immediately following 7 weeks of CALM ARC or 7 weeks of matched weekly assessments in UC.
d Conducted 6 months from the pretreatment assessment. This document is copyrighted by the American Psychological Association or one of its allied publishers.
Treatment Adherence: Therapist Fidelity and Patient Adherence
Therapists adhered to the CALM ARC protocol 99.3% of the time. The mean competence rating across all components and sessions rated on a scale from 0 (not at all competent) to 6 (highly competent) was 5.23 (SD ϭ 0.35), indicating a high level of competence. Participants in CALM ARC completed an average of 4.92 (SD ϭ 1.81) sessions and 69.2% of participants completed at least five sessions, but only 15.4% of participants completed all seven sessions. The average participant homework completion rating was 4.00 (SD ϭ 2.08), corresponding to about half of the assigned homework. Thus, the average participant in CALM ARC could be characterized as moderately engaged. Table 4 presents descriptive data and between-group effect sizes (Cohen's d) across assessment periods for outcome data.
Clinical Outcomes
Anxiety symptom outcomes (Brief Symptom Inventory [BSI-12])
. BSI scores significantly declined over time (before to after treatment) in UC ϩ CALM ARC (b ϭ Ϫ4.82, t[211.42] ϭ Ϫ4.49, p Ͻ .001) but not in UC (p ϭ .27). There was a significant time (pre, post) ϫ condition effect, b ϭ Ϫ3.61, t(323.66) ϭ Ϫ2.32, p Ͻ .05, with UC ϩ CALM ARC outperforming UC on pre-to posttreatment BSI improvement. There were no significant effects of time from after treatment to follow-up within either condition, and No Time (after treatment, follow-up) ϫ Condition Effects (all ps Ͼ .19), indicating that effects were maintained from after treatment to follow-up.
Substance use outcomes (timeline followback).
When examining pre-to posttreatment change in drinking days, withingroup tests revealed a significant effect of time in CALM ARC ϩ UC, b ϭ Ϫ2.99, t(677.44) ϭ Ϫ2.19, p Ͻ .05. In contrast, there was no statistically significant effect of time in UC (p ϭ .07).
3 There was a significant time (pre, post) ϫ condition effect, b ϭ Ϫ5.74, t(907.32) ϭ Ϫ2.83, p Ͻ .01, with CALM ARC ϩ UC participants showing greater pre-to posttreatment reductions in drinking days compared with UC. Next, we conducted a parallel set of analyses examining drug use days. Within-group tests showed no significant effect of time within UC ϩ CALM ARC (p ϭ .99) but a significant increase in days of drug use from before to after treatment in UC, b ϭ 3.18, t(1527.01) ϭ 2.53, p Ͻ .05. There was a Time (pre, post) ϫ Condition Effect that approached significance, b ϭ Ϫ3.19, t(1641.12) ϭ Ϫ1.90, p ϭ .057, 4 with UC ϩ CALM ARC outperforming UC. There were no within-or between-group effects from after treatment to follow-up on drinking days or drug use days (ps Ͼ .13), with one exception: There was a significant effect of time on drug use days within UC, b ϭ 3.90, t(161.41) ϭ 2.34, p Ͻ .05, indicating greater drug use in UC from after treatment to follow-up. Exposure to distressing and avoided stimuli, including situations, bodily sensations, images, and memories, conducted in session and assigned as homework Assigned for homework in 2-6; in session in 3-5
1. The rationale for exposure worked within the context of addiction recovery (e.g., distinguishing between adaptive exposure to feared but objectively safe situations vs. problematic exposure to external cues [i.e., people, places, and things] that may lead to substance use in early recovery) 2. Coping plans developed in the IOP were revisited in the context of managing anxiety as an internal trigger during or after exposure 3. When possible, recovery activities were woven into the exposure exercises to mutually augment one another (e.g., assigning a patient with social anxiety disorder to speak at a 12-step meeting for home practice) Relapse prevention and developing practice plans 6 Goal setting and practice plans were woven into general goal setting and relapse prevention in SUD recovery
Note. CALM ARC ϭ coordinated anxiety learning and management for addiction recovery centers; IOP ϭ intensive outpatient program; SUD ϭ substance use disorders. CALM ARC groups used closed (i.e., not rolling) admission because cognitive-behavioral therapy for anxiety disorders requires incremental skill building and practice that does not lend itself well to an open enrollment as utilized in typical IOP for SUD. CALM ARC sessions were 2 hours long (with a break), with an average of approximately six members per group. Exposures were conducted in the group room individually, as a group, or broken into smaller groups, depending on the group members' fear hierarchies. Imaginal exposures conducted in the group room were primarily done via writing. After writing, participants were instructed to read what they wrote multiple times to themselves in session and then out loud at home for repeated exposure.
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Discussion
Consistent with the hypothesis, adding CALM ARC to an SUD intensive outpatient program was superior to SUD treatment alone in reducing anxiety symptoms and substance use. These findings provide further evidence that SUD treatment alone is insufficient for comorbid anxiety disorders and SUD (see Wolitzky-Taylor et al., 2011) . Importantly, anxiety was effectively treated during SUD treatment. This finding challenges the conventional wisdom that the SUD should be treated first before anxiety can be effectively treated (Nace, 1988) , a practice that typically results in untreated mental health problems (Havassy, Alvidrez, & Mericle, 2009) .
In line with tension-reduction (e.g., Conger, 1956 ) and mutualmaintenance (Stewart & Conrod, 2008 ) models of comorbid anxiety disorders and SUD, treating anxiety symptoms that were likely to be maintaining SUD improved substance use outcomes as well. These findings add to the small body of literature supporting the use of integrated models of treatment for anxiety disorder and SUD comorbidity (e.g., Najavits et al., 2006; Kushner et al., 2006) . CALM ARC's effects are particularly notable, given its brevity, moderate level of patient engagement, and its comparison with an evidence-based treatment for SUD (Rawson et al., 1995) . Psychiatric diagnostic assessments in SUD clinics should be conducted to identify patients for whom typical SUD treatment may not exert its optimal effect without the addition of CBT to treat underlying anxiety. In contrast to the high level of fidelity to the CALM ARC protocol by SUD providers, patients were only moderately adherent. Effects may have been even larger with greater treatment engagement. Low treatment engagement and dropout are common clinical challenges in SUD populations, particularly among those with comorbid psychiatric disorders (Krawczyk et al., 2017) and are critical to address, given the link between treatment engagement and clinical outcomes (Simpson, Joe, Rowen-Szal, & Greener, 1995) . Future research should evaluate adjunctive efforts to enhance participation in CALM ARC (e.g., Miller & Rollnick, 2002) . Notably, treatment adherence was not a problem specific to the CALM ARC condition. Attrition was apparent in both conditions, even between the baseline eligibility assessment and the beginning of the treatment phase (see Figure 1) . Thus, outpatient SUD treatment seekers represent a population in need of interventions to increase treatment adherence and retention.
The primary limitation of the study was the relatively small sample size, which may have precluded us from detecting small effects. Future studies with larger samples are needed to evaluate whether findings replicate and to examine anxiety disorder-and substance-specific outcomes. Also, although the hybrid effectiveness/efficacy design is a strength of the investigation by addressing both internal and external validity, this approach is a balancing act Note. BSI-12 ϭ Brief Symptom Inventory 12-item version; CALM ARC ϭ coordinated anxiety learning and management for addiction recovery centers; FU ϭ follow-up; QOL ϭ quality of life; TLFB ϭ timeline followback; TSQ ϭ Treatment Satisfaction Questionnaire; UC ϭ usual care. Values are based on the multiply-imputed sample. Parallel analyses were run without multiple imputation and findings were generally identical. BSI scores Ͻ6 indicate mild to no symptoms, and 15.3% and 29.4% of UC participants and 34.3% and 53.8% of CALM ARC participants met this cutoff after treatment and follow-up, respectively. This document is copyrighted by the American Psychological Association or one of its allied publishers.
that naturally leaves some questions unanswered. For example, future research should examine whether CALM ARC exerts the same effects without weekly expert supervision or in less researchfriendly clinics. Uncovering mediators and moderators of CALM ARC should also be the focus of future research that can provide information to refine and augment outcomes. These preliminary findings suggest that CALM ARC is a feasible, acceptable, and effective adjunctive intervention for comorbid anxiety disorders in SUD treatment seekers. Its transdiagnostic approach makes it translatable to real-world settings, in which treating specific anxiety disorder and substance type combinations may be impractical. This study adds to the growing body of literature that aims to overcome the disconnect between typical clinical practice and the emerging theoretical (Stewart & Conrod, 2008) treatment (Kushner et al., 2006) and policy (Barry & Huskamp, 2011 ) models that argue for the advantages of an integrated model of mental health and addiction care.
